Hebory Stents


For use in arterial and venous procedures requiring percutaneous Nobori® Drug Eluting Stent is indicated for improving luminal diameter and reducing in-stent restenosis for the treatment of coronary artery lesions.

Nobori® stent has an innovative design, with biolimus A9 drug and biodegradable polymer, coated only on the abluminal side of the stent. This technology provides efficacy and preserves safety over time.